Current Opinion in Lipidology was launched in 1990. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of lipidology is divided into six sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editor and Section Editors for this issue.
Robert A. Hegele
Robert A. Hegele is a distinguished University Professor of Medicine and Biochemistry, University of Western Ontario, Canada, and Director of the Lipid Genetics Clinic and the London Regional Genomics Centre in London, Ontario, Canada.
He received his MD degree from the University of Toronto in 1981. His specialty training in internal medicine and in endocrinology & metabolism was also in Toronto. His post-doctoral research fellowships were at Rockefeller University, USA, and Howard Hughes Medical Institute, University of Utah, USA. From 1989 to 1997 he was on the Faculty of Medicine at the University of Toronto. In 1997 Dr Hegele joined the Schulich School of Medicine and Dentistry and the Robarts Research Institute at the Western University, in London, Ontario, Canada, where he holds the Jacob J. Wolfe Distinguished Medical Research Chair and the Martha Blackburn Chair in Cardiovascular Research.
His lab studies the genetics of lipoprotein metabolism, cardio¬vascular disease and diabetes mellitus. Solely or through collaborations, his lab was first to describe the molecular genetic basis of 20 human diseases. His lab has also defined much of the genetic basis of complex disorders, including hypertriglyceridemia. He has co-authored over 600 peer-reviewed publications and has contributed to national treatment guidelines for dyslipidemia, hypertension and diabetes. He is a practicing endocrinologist and has participated in numerous clinical trials. He has trained numerous physicians and graduate students.
Frank M. Sacks
Dr Sacks is Professor of Cardiovascular Disease Prevention, Departments of Nutrition and Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, USA. He is also Professor of Medicine at Harvard Medical School, USA, and a senior attending physician at Brigham and Women's Hospital where he had a specialty clinic in hyperlipidemia with the cardiovascular division. He is involved in research and public policy in nutrition, cholesterol disorders, hypertension, and cardiovascular disease.
His research program is a combination of laboratory research on human lipoprotein metabolism, and clinical trials in nutrition and cardiovascular disease. Dr Sacks was Chair of the Design Committee of the DASH study where the DASH diet was designed and tested, and Chair of the Steering Committee for the DASH-Sodium trial. Dr Sacks was Co-Chair of the OmniHeart Trial, a multicenter feeding trial that found that a variation of the DASH diet that is higher in protein or unsaturated fat diets further improved blood pressure and lipid risk factors compared to the lower fat DASH-type diet. Dr Sacks was Chair of the PoundsLost study, a 2-year trial that compared the effectiveness for weight loss of diets varying in fat, carbohydrate, and protein.
Dr Sacks is active in national and international committees and conferences in dietary and drug treatments of dyslipidemia, and nutrition and health guidelines. He was Chair of the American Heart Association Nutrition Committee. He was a member of the Hypertriglyceridemia Guidelines Committee of the Endocrine Society. He was a member of the Lifestyle Working Group of the National Heart Lung and Blood Institute Clinical Guidelines for Reducing Cardiovascular Disease which became the AHA/ACC Guidelines on Lifestyle.
Dr Sacks received the 2011 Research Achievement Award of the American Heart Association and has published 245 original research articles and 88 reviews, editorials, case reports, and letters.
Majken K. Jensen
Majken K. Jensen, PhD, is Assistant Professor of Nutrition and Genetic Epidemiology at Harvard T. H. Chan School of Public Health and Assistant Professor of Medicine at Harvard Medical School in Boston, MA, USA. Dr Jensen's primary research interests include novel metabolic markers, nutrition, and genetics, in relation to chronic lifestyle diseases. In ongoing collaborations with Dr Frank Sacks, they investigate how the presence of a small proinflammatory protein (apolipoprotein C-III) on HDL particles marks a potentially dysfunctional type of HDL that is not inversely associated with risk of cardiometabolic health, such as IMT, diabetes and cardiovascular disease. Other currently funded work is focused on lipoprotein metabolism and Alzheimer's disease and stroke. Her research predominantly utilizes large-scale observational studies (including the Health Professionals Follow-Up Study, the Nurses’ Health Study, the Danish Diet, Cancer and Health study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study) where cost-efficient prospective case-control studies are nested within for purpose of measuring novel biomarkers or genome-wide markers. Dr Jensen's research has been published in leading scientific journals and has been recognized with numerous awards. She received the Trudy Bush Fellowship for Cardiovascular Disease Research in Women's Health from the American Heart Association in 2011 and originally came for research studies at Harvard T. H. Chan School of Public Health as a Fulbright scholar. Dr Jensen has published over 80 original research articles and 5 reviews, editorials, and letters.